{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:16:12Z","timestamp":1790356572632,"version":"4.1.0"},"reference-count":82,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T00:00:00Z","timestamp":1698105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Science Foundation of Shanghai, China","award":["18ZR1431400"],"award-info":[{"award-number":["18ZR1431400"]}]},{"name":"National Science Foundation of Shanghai, China","award":["20Y11902700"],"award-info":[{"award-number":["20Y11902700"]}]},{"name":"National Science Foundation of Shanghai, China","award":["SHDC20CR40011C"],"award-info":[{"award-number":["SHDC20CR40011C"]}]},{"name":"National Science Foundation of Shanghai, China","award":["81200046"],"award-info":[{"award-number":["81200046"]}]},{"name":"Science and Technology Innovation Research Project of Shanghai Science and Technology Commission, China","award":["18ZR1431400"],"award-info":[{"award-number":["18ZR1431400"]}]},{"name":"Science and Technology Innovation Research Project of Shanghai Science and Technology Commission, China","award":["20Y11902700"],"award-info":[{"award-number":["20Y11902700"]}]},{"name":"Science and Technology Innovation Research Project of Shanghai Science and Technology Commission, China","award":["SHDC20CR40011C"],"award-info":[{"award-number":["SHDC20CR40011C"]}]},{"name":"Science and Technology Innovation Research Project of Shanghai Science and Technology Commission, China","award":["81200046"],"award-info":[{"award-number":["81200046"]}]},{"name":"Clinical Research Plan of SHDC, Shanghai, China","award":["18ZR1431400"],"award-info":[{"award-number":["18ZR1431400"]}]},{"name":"Clinical Research Plan of SHDC, Shanghai, China","award":["20Y11902700"],"award-info":[{"award-number":["20Y11902700"]}]},{"name":"Clinical Research Plan of SHDC, Shanghai, China","award":["SHDC20CR40011C"],"award-info":[{"award-number":["SHDC20CR40011C"]}]},{"name":"Clinical Research Plan of SHDC, Shanghai, China","award":["81200046"],"award-info":[{"award-number":["81200046"]}]},{"name":"National Natural Science Foundation of China, China","award":["18ZR1431400"],"award-info":[{"award-number":["18ZR1431400"]}]},{"name":"National Natural Science Foundation of China, China","award":["20Y11902700"],"award-info":[{"award-number":["20Y11902700"]}]},{"name":"National Natural Science Foundation of China, China","award":["SHDC20CR40011C"],"award-info":[{"award-number":["SHDC20CR40011C"]}]},{"name":"National Natural Science Foundation of China, China","award":["81200046"],"award-info":[{"award-number":["81200046"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The pulmonary function test (PFT) has been widely used in sarcoidosis. It may vary due to the severity, extent, and the presence of complications of the disease. Although the PFT of most sarcoidosis patients is normal, there are still 10\u201330% of cases who may experience a decrease in the PFT, with a progressive involvement of lungs. Restrictive ventilatory impairment due to parenchymal involvement has been commonly reported, and an obstructive pattern can also be present related to airway involvement. The PFT may influence treatment decisions. A diffusing capacity for carbon monoxide (DLCO) &lt; 60% as well as a forced vital capacity (FVC) &lt; 70% portends clinically significant pulmonary sarcoidosis pathology and warrants treatment. During follow-up, a 5% decline in FVC from baseline or a 10% decline in DLCO has been considered significant and reflects the disease progression. FVC has been recommended as the favored objective endpoint for monitoring the response to therapy, and an improvement in predicted FVC percentage of more than 5% is considered effective.<\/jats:p>","DOI":"10.3390\/jcm12216701","type":"journal-article","created":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T11:39:04Z","timestamp":1698147544000},"page":"6701","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Pulmonary Function in Pulmonary Sarcoidosis"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7146-7640","authenticated-orcid":false,"given":"Qian","family":"Yao","sequence":"first","affiliation":[{"name":"Department of Clinical Research Unit, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200443, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuliang","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Clinical Research Unit, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200443, China"},{"name":"Department of Pulmonary and Critical Care Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"S\u00e8ve, P., Pacheco, Y., Durupt, F., Jamilloux, Y., Gerfaud-Valentin, M., Isaac, S., Boussel, L., Calender, A., Androdias, G., and Valeyre, D. (2021). Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis. Cells, 10.","DOI":"10.3390\/cells10040766"},{"key":"ref_2","unstructured":"Statement on sarcoidosis (1999). Joint statement of the american thoracic society (ATS), the european respiratory society (ERS) and the world association of sarcoidosis and other granulomatous disorders (WASOG) adopted by the ATS board of directors and by the ERS executive committee, february 1999. Am. J. Respir. Crit. Care Med., 160, 736\u2013755."},{"key":"ref_3","first-page":"90","article-title":"Endpoints for clinical trials of sarcoidosis","volume":"29","author":"Baughman","year":"2012","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1378\/chest.127.2.472","article-title":"Endoluminal stenosis of proximal bronchi in sarcoidosis: Bronchoscopy, function, and evolution","volume":"127","author":"Chambellan","year":"2005","journal-title":"Chest"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S2213-2600(13)70276-5","article-title":"An integrated clinicoradiological staging system for pulmonary sarcoidosis: A case-cohort study","volume":"2","author":"Walsh","year":"2014","journal-title":"Lancet Respir. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1378\/chest.128.3.1483","article-title":"Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension","volume":"128","author":"Sulica","year":"2005","journal-title":"Chest"},{"key":"ref_7","first-page":"167","article-title":"Sarcoidosis: A long-term follow up study","volume":"17","author":"Chappell","year":"2000","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000196564","article-title":"Are the pulmonary function tests and the markers of activity helpful to establish the prognosis of sarcoidosis?","volume":"63","author":"Mana","year":"1996","journal-title":"Respiration"},{"key":"ref_9","first-page":"154","article-title":"Predicting respiratory failure in sarcoidosis patients","volume":"14","author":"Baughman","year":"1997","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1183\/09031936.93.06030349","article-title":"Vital prognosis in intrathoracic sarcoidosis with special reference to pulmonary function and radiological stage","volume":"6","author":"Viskum","year":"1993","journal-title":"Eur. Respir. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.46497\/ArchRheumatol.2020.7584","article-title":"Sarcoidosis in jordan: A study of the clinical phenotype and disease outcome","volume":"35","author":"Alnaimat","year":"2020","journal-title":"Arch. Rheumatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1378\/chest.130.6.1851","article-title":"Clinical and radiographic indices associated with airflow limitation in patients with sarcoidosis","volume":"130","author":"Handa","year":"2006","journal-title":"Chest"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/j.sult.2018.12.001","article-title":"Pulmonary sarcoidosis: A pictorial review","volume":"40","author":"Iranmanesh","year":"2019","journal-title":"Semin. Ultrasound CT MR"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1183\/09031936.00187410","article-title":"Stage IV sarcoidosis: Comparison of survival with the general population and causes of death","volume":"38","author":"Nardi","year":"2011","journal-title":"Eur. Respir. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"S569","DOI":"10.21037\/jtd.2016.07.30","article-title":"Key management considerations in sarcoidosis from the American Thoracic Society 2016 Conference","volume":"8","author":"Liang","year":"2016","journal-title":"J. Thorac. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"(2013). Baughman RP, Nunes H, Sweiss NJ, Lower EE: Established and experimental medical therapy of pulmonary sarcoidosis. Eur. Respir. J., 41, 1424\u20131438.","DOI":"10.1183\/09031936.00060612"},{"key":"ref_17","first-page":"e18","article-title":"Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline","volume":"1","author":"Ganesh","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1183\/09031936.00224513","article-title":"Rituximab in the treatment of refractory pulmonary sarcoidosis","volume":"43","author":"Sweiss","year":"2014","journal-title":"Eur. Respir. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1378\/chest.94.2.343","article-title":"Airway obstruction in sarcoidosis. A study of 123 nonsmoking black American patients with sarcoidosis","volume":"94","author":"Sharma","year":"1988","journal-title":"Chest"},{"key":"ref_20","first-page":"147","article-title":"Pulmonary and psychosocial findings at enrollment in the ACCESS study","volume":"22","author":"Yeager","year":"2005","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12016-015-8475-x","article-title":"Diagnosis of sarcoidosis","volume":"49","author":"Wessendorf","year":"2015","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.21037\/jtd.2017.01.17","article-title":"Relationship between radiologic patterns, pulmonary function values and bronchoalveolar lavage fluid cells in newly diagnosed sarcoidosis","volume":"9","author":"Aleksoniene","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1183\/09031936.00025212","article-title":"Imaging of sarcoidosis of the airways and lung parenchyma and correlation with lung function","volume":"40","author":"Nunes","year":"2012","journal-title":"Eur. Respir. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_25","first-page":"204","article-title":"Two year prognosis of sarcoidosis: The ACCESS experience","volume":"20","author":"Judson","year":"2003","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1440-1843.2007.01206.x","article-title":"The utility of the chest radiograph in diagnosing exacerbations of pulmonary sarcoidosis","volume":"13","author":"Judson","year":"2008","journal-title":"Respirology"},{"key":"ref_27","first-page":"130","article-title":"Optimal scoring of serial change on chest radiography in sarcoidosis","volume":"28","author":"Zappala","year":"2011","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.2214\/ajr.174.6.1741751","article-title":"Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function","volume":"174","author":"Abehsera","year":"2000","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/2049-6958-8-8","article-title":"HRCT findings of pulmonary sarcoidosis; Relation to pulmonary function tests","volume":"8","author":"Ors","year":"2013","journal-title":"Multidiscip. Respir. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1148\/radiology.209.3.9844661","article-title":"Pulmonary sarcoidosis: Morphologic associations of airflow obstruction at thin-section CT","volume":"209","author":"Hansell","year":"1998","journal-title":"Radiology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1053\/crad.1999.0366","article-title":"Air trapping in sarcoidosis on computed tomography: Correlation with lung function","volume":"55","author":"Davies","year":"2000","journal-title":"Clin. Radiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.rmed.2012.11.011","article-title":"Severity of pulmonary involvement and (18)F-FDG PET activity in sarcoidosis","volume":"107","author":"Mostard","year":"2013","journal-title":"Respir. Med."},{"key":"ref_33","first-page":"37","article-title":"Extent of disease activity assessed by 18F-FDG PET\/CT in a Dutch sarcoidosis population","volume":"31","author":"Cremers","year":"2014","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_34","first-page":"242","article-title":"The importance of PET\/CT findings and hematological parameters in prediction of progression in sarcoidosis cases","volume":"34","author":"Kemal","year":"2017","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_35","first-page":"123","article-title":"18F-FDG PET as a predictor of pulmonary function in sarcoidosis","volume":"28","author":"Keijsers","year":"2011","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1183\/09031936.00227014","article-title":"Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis","volume":"46","author":"Vorselaars","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_37","first-page":"143","article-title":"18F-FDG PET in sarcoidosis: An observational study in 12 patients treated with infliximab","volume":"25","author":"Keijsers","year":"2008","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2213-2600(18)30064-X","article-title":"Pulmonary sarcoidosis","volume":"6","author":"Spagnolo","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1513\/AnnalsATS.201303-069FR","article-title":"Pulmonary fibrosis in sarcoidosis. Clinical features and outcomes","volume":"10","author":"Patterson","year":"2013","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.chest.2017.07.008","article-title":"Predictors of mortality in pulmonary sarcoidosis","volume":"153","author":"Kirkil","year":"2018","journal-title":"Chest"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Boucly, A., Cottin, V., Nunes, H., Jais, X., Tazi, A., Prevot, G., Reynaud-Gaubert, M., Dromer, C., Viacroze, C., and Horeau-Langlard, D. (2017). Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension. Eur. Respir. J., 50.","DOI":"10.1183\/13993003.00465-2017"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1378\/chest.129.5.1246","article-title":"Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis","volume":"129","author":"Handa","year":"2006","journal-title":"Chest"},{"key":"ref_43","first-page":"37","article-title":"Diagnosis issues in sarcoidosis","volume":"77","author":"Jeny","year":"2020","journal-title":"Respir. Med. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1378\/chest.09-2002","article-title":"Survival in sarcoidosis-associated pulmonary hypertension: The importance of hemodynamic evaluation","volume":"138","author":"Baughman","year":"2010","journal-title":"Chest"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1183\/09031936.00175511","article-title":"Management of end-stage sarcoidosis: Pulmonary hypertension and lung transplantation","volume":"39","author":"Shlobin","year":"2012","journal-title":"Eur. Respir. J."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Savale, L., Huitema, M., Shlobin, O., Kouranos, V., Nathan, S.D., Nunes, H., Gupta, R., Grutters, J.C., Culver, D.A., and Post, M.C. (2022). WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension. Eur. Respir. Rev., 31.","DOI":"10.1183\/16000617.0165-2021"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1183\/09031936.00175907","article-title":"Clinical predictors of pulmonary hypertension in sarcoidosis","volume":"32","author":"Bourbonnais","year":"2008","journal-title":"Eur. Respir. J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1901747","DOI":"10.1183\/13993003.01747-2019","article-title":"Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: Results from an international registry","volume":"55","author":"Shlobin","year":"2020","journal-title":"Eur. Respir. J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1164\/rccm.2111053","article-title":"Idiopathic pulmonary fibrosis: A composite physiologic index derived from disease extent observed by computed tomography","volume":"167","author":"Wells","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00408-017-9994-4","article-title":"Repository corticotropin for Chronic Pulmonary Sarcoidosis","volume":"195","author":"Baughman","year":"2017","journal-title":"Lung"},{"key":"ref_51","first-page":"86","article-title":"A composite score to assess treatment response in pulmonary sarcoidosis: The Sarcoidosis Treatment Score (STS)","volume":"36","author":"Baughman","year":"2019","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s41030-023-00222-2","article-title":"Results from a phase 4, multicenter, randomized, Double-Blind, Placebo-Controlled study of repository corticotropin injection for the treatment of pulmonary sarcoidosis","volume":"9","author":"Mirsaeidi","year":"2023","journal-title":"Pulm. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12931-022-01993-z","article-title":"Clinical phenotyping in sarcoidosis using cluster analysis","volume":"23","author":"Lin","year":"2022","journal-title":"Respir. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1378\/chest.06-2822","article-title":"Six-minute walk test and health status assessment in sarcoidosis","volume":"132","author":"Baughman","year":"2007","journal-title":"Chest"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/IJGM.S334019","article-title":"Physical activity and respiratory muscle strength in patients with sarcoidosis: An observational study","volume":"15","author":"Pescaru","year":"2022","journal-title":"Int. J. Gen. Med."},{"key":"ref_56","first-page":"82","article-title":"Treatment of sarcoidosis-associated pulmonary hypertension: A single centre retrospective experience using targeted therapies","volume":"31","author":"Keir","year":"2014","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1378\/chest.08-1881","article-title":"Treatment of sarcoidosis-associated pulmonary hypertension. A two-center experience","volume":"135","author":"Barnett","year":"2009","journal-title":"Chest"},{"key":"ref_58","first-page":"49","article-title":"C-reactive protein predicts response to infliximab in patients with chronic sarcoidosis","volume":"27","author":"Sweiss","year":"2010","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/MCP.0b013e328273bc2b","article-title":"Six-minute walk test in managing and monitoring sarcoidosis patients","volume":"13","author":"Baughman","year":"2007","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00408-012-9432-6","article-title":"Is there an added value of cardiopulmonary exercise testing in sarcoidosis patients?","volume":"191","author":"Marcellis","year":"2013","journal-title":"Lung"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/RTI.0000000000000198","article-title":"Computed Tomographic Scoring Systems in Sarcoidosis: Comparison With Cardiopulmonary Exercise Testing Parameters","volume":"31","author":"Jeong","year":"2016","journal-title":"J. Thorac. Imaging."},{"key":"ref_62","first-page":"185","article-title":"Spirometry, cardiopulmonary exercise testing and the six-minute walk test results in sarcoidosis patients","volume":"36","author":"Kiani","year":"2019","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"ref_63","first-page":"123","article-title":"Outcome of pulmonary sarcoidosis: A population-based study 1976\u20132013","volume":"35","author":"Ungprasert","year":"2018","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.rmed.2012.01.013","article-title":"The treatment of pulmonary sarcoidosis","volume":"106","author":"Judson","year":"2012","journal-title":"Respir. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1378\/chest.116.2.424","article-title":"Oral prednisolone followed by inhaled budesonide in newly diagnosed pulmonary sarcoidosis: A double-blind, placebo-controlled multicenter study. Finnish Pulmonary Sarcoidosis Study Group","volume":"116","author":"Pietinalho","year":"1999","journal-title":"Chest"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1183\/09031936.99.13613519","article-title":"Randomized trial of inhaled fluticasone propionate in chronic stable pulmonary sarcoidosis: A pilot study","volume":"13","author":"Greenhalgh","year":"1999","journal-title":"Eur. Respir. J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1378\/chest.121.1.24","article-title":"Early treatment of stage II sarcoidosis improves 5-year pulmonary function","volume":"121","author":"Pietinalho","year":"2002","journal-title":"Chest"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","article-title":"Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement","volume":"174","author":"Baughman","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1702089","DOI":"10.1183\/13993003.02089-2017","article-title":"Daily home spirometry to detect early steroid treatment effects in newly treated pulmonary sarcoidosis","volume":"51","author":"Broos","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.rmed.2017.10.022","article-title":"No evidence found for an association between prednisone dose and FVC change in newly-treated pulmonary sarcoidosis","volume":"138S","author":"Broos","year":"2018","journal-title":"Respir. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2004079","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-019-0096-x","article-title":"Sarcoidosis","volume":"5","author":"Grunewald","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1378\/chest.111.3.623","article-title":"Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy","volume":"111","author":"Gottlieb","year":"1997","journal-title":"Chest"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/jama.287.10.1301","article-title":"Corticosteroid therapy in pulmonary sarcoidosis: A systematic review","volume":"287","author":"Paramothayan","year":"2002","journal-title":"JAMA"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.rmed.2009.12.009","article-title":"Pharmacotherapy for pulmonary sarcoidosis: A Delphi consensus study","volume":"104","author":"Schutt","year":"2010","journal-title":"Respir. Med."},{"key":"ref_76","first-page":"60","article-title":"Methotrexate is steroid sparing in acute sarcoidosis: Results of a double blind, randomized trial","volume":"17","author":"Baughman","year":"2000","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1378\/chest.12-1728","article-title":"Methotrexate vs azathioprine in second-line therapy of sarcoidosis","volume":"144","author":"Vorselaars","year":"2013","journal-title":"Chest"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"(2002). Vucinic VM: What is the future of methotrexate in sarcoidosis? A study and review. Curr. Opin. Pulm. Med., 8, 470\u2013476.","DOI":"10.1097\/00063198-200209000-00022"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1001\/archinte.1995.00430080088011","article-title":"Prolonged use of methotrexate for sarcoidosis","volume":"155","author":"Lower","year":"1995","journal-title":"Arch. Intern. Med."},{"key":"ref_80","first-page":"217","article-title":"Effectiveness and tolerability of methotrexate in pulmonary sarcoidosis: A single center real-world study","volume":"36","author":"Fang","year":"2019","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000345596","article-title":"Effect and safety of mycophenolate mofetil in chronic pulmonary sarcoidosis: A retrospective study","volume":"86","author":"Brill","year":"2013","journal-title":"Respiration"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.rmed.2014.09.013","article-title":"Efficacy of mycophenolate mofetil in sarcoidosis","volume":"108","author":"Hamzeh","year":"2014","journal-title":"Respir. Med."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/21\/6701\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:10:36Z","timestamp":1760130636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/21\/6701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,24]]},"references-count":82,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["jcm12216701"],"URL":"https:\/\/doi.org\/10.3390\/jcm12216701","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,24]]}}}